Abstract
A series of complexes of platinum(IV) (C1–C5) and zinc(II) (C6–C10) with S-alkyl derivatives of thiosalicylic acid were prepared and characterized. The interactions of the complexes with calf thymus DNA were analyzed by absorption (UV–Vis) and emission spectral studies (ethidium bromide displacement studies). The cytotoxic activities of complexes C1–C10 were determined against mouse B cell lymphocytic leukemia cells (BCL1), human B-prolymphocytic leukemia (JVM-13), mouse mammary carcinoma cells (4T1), and human mammary carcinoma cells (MDA-MB-468) and compared to the activities of the free ligand precursors and cisplatin. The cytotoxicities of the platinum(IV) and zinc(II) complexes toward mouse tumor cell lines were higher compared with their effects on human tumor cell lines. The zinc(II) complex C9 showed the highest antitumor activity toward the tested human cell lines, while the platinum(IV) complex C4 exhibited the highest antitumor activity toward mouse BCL1 and 4T1 cells. Both C4 and C9 have ligands derived from S-propyl thiosalicylic acid.
Similar content being viewed by others
References
Rabik CA, Dolan ME (2007) Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev 33(1):9–23
Prestayko AW, D’Aoust JC, Issell BF, Crooke ST (1979) Cisplatin (cis-diamminedichloroplatinum II). Cancer Treat Rev 6(1):17–39
Florea AM, Büsselberg D (2011) Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers 3(1):1351–1371
Jakupec MA, Galanski M, Arion VB, Hartinger CG, Keppler BK (2008) Antitumour metal compounds: more than theme and variations. Dalton Trans 2:183–194
Tang B, Wan D, Wang YJ, Yi QY, Guo BH, Liu YJ (2018) An iridium (III) complex as potent anticancer agent induces apoptosis and autophagy in B16 cells through inhibition of the AKT/mTOR pathway. Eur J Med Chem 145:302–314
Yi QY, Wan D, Tang B, Wang YJ, Zhang WY, Du F, He M, Liu YJ (2018) Synthesis, characterization and anticancer activity in vitro and in vivo evaluation of an iridium (III) polypyridyl complex. Eur J Med Chem 145:338–349
Liang ZH, Wan D, Yi QY, Zhang WY, Liu YJ (2018) A cyclometalated iridium(III) complex induces apoptosis and autophagy through inhibition of the PI3 K/AKT/mTOR pathway. Transit Metal Chem 43(3):243–257
Zhang WY, Yi QY, Wang YJ, Du F, He M, Tang B, Wan D, Liu YJ, Huang HL (2018) Photoinduced anticancer activity studies of iridium(III) complexes targeting mitochondria and tubules. Eur J Med Chem 151:568–584
Wilson JJ, Lippard SJ (2014) Synthetic methods for the preparation of platinum anticancer complexes. Chem Rev 114(8):4470–4495
Arsenijević M, Milovanović M, Volarević V, Čanović D, Arsenijević N, Soldatović T, Jovanović S, Bugarčić ŽD (2012) Cytotoxic properties of platinum(IV) and dinuclear platinum (II) complexes and their ligand substitution reactions with guanosine-5`-monophosphate. Transit Metal Chem 37:481–488
Vujić JM, Kaluđerović GN, Milovanović M, Zmejkoviski BB, Volarević V, Živić D, Đurđević P, Arsenijević N, Trifunović S (2011) Stereospecific ligands and their complexes: part VII synthesis, characterization and in vitro antitumoral activity of platinum(II) complexes with O, O′-dialkyl esters of (S, S)-ethylenediamineN, N′-di-2-(4-methyl) pentanoic acid. Eur J Med Chem 46(9):4559–4565
Hall MD, Mellor HR, Callaghan R, Hambley TW (2007) Basis for design and development of platinum(IV) anticancer complexes. J Med Chem 50(15):3403–3411
Tolan D, Gandin V, Morrison L, El-Nahas A, Marzano C, Montagner D, Erxleben A (2016) Oxidative stress induced by Pt(IV) pro-drugs based on the cisplatin scaffold and indole carboxylic acids in axial position. Sci Rep 6:29367
Choi S, Filotto C, Bisanzo M, Delaney S, Lagasee D, Whitworth JL, Jusko A, Li C, Wood NA, Willingham J, Schwenker A, Spaulding K (1998) Reduction and anticancer activity of platinum(IV) complexes. Inorg Chem 37(10):2500–2504
Pendyala L, Creaven PJ, Perez R, Zdanowicz JR, Raghavan D (1995) Intracellular glutathione and cytotoxicity of platinum complexes. Cancer Chemother Pharmacol 36(4):271–278
Han X, Sun J, Wang Y, He Z (2015) Recent advances in platinum(IV) complex-based delivery systems to improve platinum(II) anticancer therapy. Med Res Rev 35(6):1268–1299
Jung Y, Lippard SJ (2007) Direct cellular responses to platinum-induced DNA damage. Chem Rev 107(5):1387–1407
Strohfeldt K, Tacke M (2008) Bioorganometallic fulvene-derived titanocene anti-cancer drugs. Chem Soc Rev 37(6):1174–1187
Chen ZF, Shi YF, Liu YC, Hong X, Geng B, Peng Y, Liang H (2012) TCM active ingredient oxoglaucine metal complexes: crystal structure, cytotoxicity, and interaction with DNA. Inorg Chem 51(4):1998–2009
Federico A, Iodice P, Federico P, Del Rio A, Mellone MC, Catalano G, Federico P (2001) Effects of selenium and zinc supplementation on nutritional status in patients with cancer of digestive tract. Eur J Clin Nutr 55(4):293–297
Prasad AS, Beck FW, Doerr TD, Shamsa FH, Penny HS, Marks SC, Kaplan J, Kucuk O, Mathog RH (1998) Nutritional and zinc status of head and neck cancer patients: an interpretive review. J Am Coll Nutr 17(5):409–418
Oteiza PI, Clegg MS, Zago MP, Keen CL (2000) Zinc deficiency induces oxidative stress and AP-1 activation in 3T3 cells. Free Radic Biol Med 28(7):1091–1099
Golub MS, Gershwin ME, Hurley LS, Hendrickx AG, Saito WY (1985) Studies of marginal zinc deprivation in rhesus monkeys: infant behavior. Am J Clin Nutr 42(6):1229–1239
Gauna GA, Marino J, García Vior MC, Roguin LP, Awruch J (2011) Synthesis and comparative photodynamic properties of two isosteric alkyl substituted zinc(II) phthalocyanines. Eur J Med Chem 46(11):5532–5539
Enyedy É, Nagy N, Zsigó É, Kowol C, Arion V, Keppler B, Kiss T (2010) Comparative solution equilibrium study of the interactions of copper(II), iron(II) and zinc(II) with triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone) and related ligands. Eur J Inorg Chem 11:1717–1728
Li MX, Zhang LZ, Yang M, Niu JY, Zhou J (2012) Synthesis, crystal structures, in vitro biological evaluation of zinc(II) and bismuth(III) complexes of 2-acetylpyrazine N (4)-phenylthiosemicarbazone. Bioorg Med Chem Lett 22(7):2418–2423
Tomovic D, Bukonjic A, Jevtic V, Ratkovic Z, Bogojeski J, Djekovic A, Radojevic I, Lj Comic, Novakovic S, Bogdanovic G, Trifunovic S, Radic G, Cupara S (2018) DNA binding, antibacterial and antifungal activities of copper(II) complexes with some S-alkenyl derivatives of thiosalicylic acid. Transit Metal Chem 43(2):137–148
Nikolić MV, Mijajlović MŽ, Jevtić VV, Ratković ZR, Novaković SB, Bogdanović GA, Milovanović J, Arsenijević A, Stojanović B, Trifunović SR, Radić GP (2016) Cytotoxicity of copper(II)-complexes with some S-alkyl derivatives of thiosalicylic acid. Crystal structure of the binuclear copper(II)-complex with S-ethyl derivative of thiosalicylic acid. J Mol Struct 1116:264–271
Nikolić MV, Mijajlović MŽ, Jevtić VV, Ratković ZR, Radojević ID, LjR Čomić, Novaković SB, Bogdanović GA, Trifunović SR, Radić GP (2014) Synthesis, characterization and antimicrobial activity of copper(II) complexes with some S-alkyl derivatives of thiosalicylic acid. Crystal structure of the binuclear copper(II) complex with S-methyl derivative of thiosalicylic acid. Polyhedron 79:80–87
Mijajlović MŽ, Nikolić MV, Tomović DLj, Bukonjić AM, Kočović A, Jevtić VV, Ratković ZR, Klisurić O, Trifunović SR, Radić GP (2017) Synthesis and characterization of platinum(IV)-complexes with some S-alkyl derivatives of thiosalicylic acid. Crystal structure of the S-butyl derivative of thiosalicylic acid. Serbian J Exp Clin Res 18(3):195–201
Nikolić M, Mijajlović MŽ, Tomović DLj, Bukonjić AM, Jevtić VV, Ratković ZR, Trifunović SR, Radić GP (2017) Synthesis and characterization of zinc(II)-complexes with some S-alkyl derivatives of thiosalicylic acid. Serbian J Exp Clin Res. https://doi.org/10.1515/sjecr-2017-0005
Dimiza F, Fountoulaki S, Papadopoulos AN, Kontogiorgis CA, Tangoulis V, Raptopoulou CP, Psycharis V, Terzis A, Kessissoglou DP, Psomas G (2011) Non-steroidal antiinflammatory drug–copper(II) complexes: structure and biological perspectives. Dalton Trans 40:8555–8568
Dimiza F, Perdih F, Tangoulis V, Turel I, Kessissoglou DP, Psomas G (2011) Interaction of copper(II) with the non-steroidal anti-inflammatory drugs naproxen and diclofenac: synthesis, structure, DNA-and albumin-binding. J Inorg Biochem 105:476–489
Ćoćić D, Jovanović S, Nišavić M, Baskić D, Todorović D, Popović S, Bugarčić ŽD, Petrović B (2017) New dinuclear palladium(II) complexes: studies of the nucleophilic substitution reactions, DNA/BSA interactions and cytotoxic activity. J Inorg Biochem 175:67–79
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1–2):55–63
Huynh HV, Yeo CH, Chew YX (2010) Syntheses, structures and catalytic activities of hemilabile thioether-functionalized NHC complexes. Organometallics 29(6):1479–1486
Novakova O, Chen H, Vrana O, Rodger A, Sadler PJ, Brabec V (2003) DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media. Biochemistry 42:11544–11554
Milutinović MM, Bogojeski JV, Klisurić O, Scheurer A, Elmrothd SKC, Bugarčić ŽD (2016) Synthesis and structures of a pincer-type rhodium(III) complex: reactivity toward biomolecules. Dalton Trans 45:15481–15491
Recio Despaigne AA, Da Silva JG, da Costa PR, dos Santos RG, Beraldo H (2014) ROS-mediated cytotoxic effect of copper(II) hydrazone complexes against human glioma cells. Molecules 19(11):17202–17220
Theiner S, Varbanov HP, Galanski M, Egger AE, Berger W, Heffeter P, Keppler BK (2015) Comparative in vitro and in vivo pharmacological investigation of platinum(IV) complexes as novel anticancer drug candidates for oral application. J Biol Inorg Chem 20(1):89–99
Varbanov HP, Göschl S, Heffeter P, Theiner S, Roller A, Jensen F, Jakupec MA, Berger W, Galanski M, Keppler BK (2014) A novel class of bis- and tris-chelate diam(m)inebis(dicarboxylato)platinum(IV) complexes as potential anticancer prodrugs. J Med Chem 57(15):6751–6764
Ma L, Lin X, Li C, Xu Z, Chan CY, Tse MK, Shi P, Zhu G (2018) A cancer cell-selective and low-toxic bifunctional heterodinuclear Pt(IV)–Ru(II) anticancer prodrug. Inorg Chem 57(5):2917–2924
Hu W, Zhao J, Hua W, Gou S (2018) A study on platinum(iv) species containing an estrogen receptor modulator to reverse tamoxifen resistance of breast cancer. Metallomics 10(2):346–359
Belkacemi L, Atkins JL, Yang LU, Gadgil P, Sater AK, Chow DS, Bose RN, Zhang SX (2018) Phosphaplatin anti-tumor effect enhanced by liposomes partly via an up-regulation of PEDF in breast cancer. Anticancer Res 38(2):623–646
Ikeda NE, Novak EM, Maria DA, Velosa AS, Pereira RM (2015) Synthesis, characterization and biological evaluation of Rutin-zinc(II) flavonoid -metal complex. Chem Biol Interact 239:184–191
Pahontu E, Fala V, Gulea A, Poirier D, Tapcov V, Rosu T (2013) Synthesis and characterization of some new Cu(II), Ni(II) and Zn(II) complexes with salicylidene thiosemicarbazones: antibacterial, antifungal and in vitro antileukemia activity. Molecules 18(8):8812–8836
Li MX, Zhang LZ, Chen CL, Niu JY, Ji BS (2012) Synthesis, crystal structures, and biological evaluation of Cu(II) and Zn(II) complexes of 2-benzoylpyridine Schiff bases derived from S-methyl- and S-phenyldithiocarbazates. J Inorg Biochem 106(1):117–125
Acknowledgements
This work was funded by grants from the Serbian Ministry of Science and Technological Development (Grants Nos. ON175069, ON172016, and ON172011), Serbia, and the Faculty of Medical Sciences, University of Kragujevac (MP 01/14 and MP 02/14).
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Besser Silconi, Z., Benazic, S., Milovanovic, J. et al. DNA binding and antitumor activities of platinum(IV) and zinc(II) complexes with some S-alkyl derivatives of thiosalicylic acid. Transit Met Chem 43, 719–729 (2018). https://doi.org/10.1007/s11243-018-0260-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11243-018-0260-2